v3.26.1
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Reconciliation of Revenue and Significant Segment Items to Net Loss The table below presents selected financial information of the
Company’s single reportable segment regularly provided to and reviewed by the CODM and a reconciliation of segment net loss to consolidated net loss as computed under U.S. GAAP:
Three Months Ended June 30,Six Months Ended
June 30,
2026202520262025
Revenue:
Jeuveau®
$74,456 $58,968 $140,477 $127,042 
Evolysse®
8,894 9,731 15,620 9,731 
Total product revenue, net83,350 68,699 156,097 136,773 
Service revenue734 688 1,124 1,136 
Total net revenues84,084 69,387 157,221 137,909 
Less:
Cost of goods sold
26,904 24,067 51,144 45,934 
Gross profit57,180 45,320 106,077 91,975 
Less:
Research and development
1,892 1,837 4,132 4,049 
Selling, general and administrative
57,052 56,675 109,033 113,315 
Depreciation and amortization
1,529 932 3,067 1,756 
Interest income
(296)(479)(581)(1,189)
Interest expense
4,172 7,207 8,147 11,622 
Income tax (benefit) expense(154)53 102 125 
Other segment items(1)
1,037 (3,763)903 (1,669)
Segment net loss$(8,052)$(17,142)$(18,726)$(36,034)
Reconciliation of profit and loss (Segment net loss/profit):
Adjustments and reconciling items
— — — — 
Consolidated net loss$(8,052)$(17,142)$(18,726)$(36,034)
(1) Other segment items include revaluation of contingent royalty obligation payable to Evolus Founders and Other (income) expense, net.